DexCom, Inc. (DXCM) closed at $90.22 on August 21, 2026, slipping 0.52% over the prior 24 hours and extending a modest weekly pullback of 0.83%. Despite the near-term softness, the medical device maker's shares remain sharply higher on a monthly basis.
The 30-day gain of 24.92% represents a substantial move for the continuous glucose monitor maker, pushing its market capitalization to $33.92 billion. That longer-term advance has dominated the stock's recent trading narrative even as momentum cooled slightly into the end of the week.
The minor daily and weekly declines suggest some consolidation following the strong monthly run. Trading activity reflected a measured pullback rather than any broad reversal of the gains accumulated over the past month.
At $90.22, DXCM continues to trade well above where it stood 30 days ago, with the market capitalization of $33.92 billion reflecting the stock's elevated standing relative to recent history.
